These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
193 related articles for article (PubMed ID: 27556183)
1. Ets2 knockdown inhibits tumorigenesis in esophageal squamous cell carcinoma in vivo and in vitro. Li Q; Yang L; Han K; Zhu L; Zhang Y; Ma S; Zhang K; Yang B; Guan F Oncotarget; 2016 Sep; 7(38):61458-61468. PubMed ID: 27556183 [TBL] [Abstract][Full Text] [Related]
2. [Effects of mTOR siRNA on mTOR/p70S6K signaling pathway in esophageal squamous cell carcinoma cells and the growth of transplanted tumor in nude mice]. Liu MY; Hou GQ; Zhang Y; Bei WJ; Yan AH Zhonghua Zhong Liu Za Zhi; 2011 May; 33(5):334-9. PubMed ID: 21875460 [TBL] [Abstract][Full Text] [Related]
3. Peroxiredoxin 1 promotes tumorigenesis through regulating the activity of mTOR/p70S6K pathway in esophageal squamous cell carcinoma. Gong F; Hou G; Liu H; Zhang M Med Oncol; 2015 Feb; 32(2):455. PubMed ID: 25579166 [TBL] [Abstract][Full Text] [Related]
4. Pseudogene PHBP1 promotes esophageal squamous cell carcinoma proliferation by increasing its cognate gene PHB expression. Feng F; Qiu B; Zang R; Song P; Gao S Oncotarget; 2017 Apr; 8(17):29091-29100. PubMed ID: 28404970 [TBL] [Abstract][Full Text] [Related]
5. Phosphorylated p70S6K expression is an independent prognosticator for patients with esophageal squamous cell carcinoma. Li SH; Chen CH; Lu HI; Huang WT; Tien WY; Lan YC; Lee CC; Chen YH; Huang HY; Chang AY; Lin WC Surgery; 2015 Mar; 157(3):570-80. PubMed ID: 25726316 [TBL] [Abstract][Full Text] [Related]
6. MiR-214 promotes cell meastasis and inhibites apoptosis of esophageal squamous cell carcinoma via PI3K/AKT/mTOR signaling pathway. Guanen Q; Junjie S; Baolin W; Chaoyang W; Yajuan Y; Jing L; Junpeng L; Gaili N; Zhongping W; Jun W Biomed Pharmacother; 2018 Sep; 105():350-361. PubMed ID: 29864623 [TBL] [Abstract][Full Text] [Related]
7. Bit1 knockdown contributes to growth suppression as well as the decreases of migration and invasion abilities in esophageal squamous cell carcinoma via suppressing FAK-paxillin pathway. Fan T; Chen J; Zhang L; Gao P; Hui Y; Xu P; Zhang X; Liu H Mol Cancer; 2016 Mar; 15():23. PubMed ID: 26956728 [TBL] [Abstract][Full Text] [Related]
8. Thioridazine Sensitizes Esophageal Carcinoma Cell Lines to Radiotherapy-Induced Apoptosis In Vitro and In Vivo. Li H; Juan L; Xia L; Wang Y; Bao Y; Sun G Med Sci Monit; 2016 Jul; 22():2624-34. PubMed ID: 27453171 [TBL] [Abstract][Full Text] [Related]
9. Effects of bufalin on the mTOR/p70S6K pathway and apoptosis in esophageal squamous cell carcinoma in nude mice. Liu Y; Wang X; Jia Y; Liu Y Int J Mol Med; 2017 Aug; 40(2):357-366. PubMed ID: 28656204 [TBL] [Abstract][Full Text] [Related]
10. Knockdown of HOXA5 inhibits the tumorigenesis in esophageal squamous cell cancer. Zhang H; Zhao JH; Suo ZM Biomed Pharmacother; 2017 Feb; 86():149-154. PubMed ID: 27960137 [TBL] [Abstract][Full Text] [Related]
11. Downregulation of p70S6K Enhances Cell Sensitivity to Rapamycin in Esophageal Squamous Cell Carcinoma. Lu Z; Peng K; Wang N; Liu HM; Hou G J Immunol Res; 2016; 2016():7828916. PubMed ID: 27595116 [TBL] [Abstract][Full Text] [Related]
12. GOLPH3 promotes cell proliferation and tumorigenicity in esophageal squamous cell carcinoma via mTOR and Wnt/β‑catenin signal activation. Wang JH; Yuan LJ; Liang RX; Liu ZG; Li BH; Wen ZS; Huang ST; Zheng M Mol Med Rep; 2017 Nov; 16(5):7138-7144. PubMed ID: 28901498 [TBL] [Abstract][Full Text] [Related]
13. OP16, a novel ent-kaurene diterpenoid, potentiates the antitumor effect of rapamycin by inhibiting rapamycin-induced feedback activation of Akt signaling in esophageal squamous cell carcinoma. Peng KZ; Ke Y; Zhao Q; Tian F; Liu HM; Hou G; Lu Z Biochem Pharmacol; 2017 Sep; 140():16-27. PubMed ID: 28539264 [TBL] [Abstract][Full Text] [Related]
14. DEPTOR suppresses the progression of esophageal squamous cell carcinoma and predicts poor prognosis. Ji YM; Zhou XF; Zhang J; Zheng X; Li SB; Wei ZQ; Liu T; Cheng DL; Liu P; Song K; Tan T; Zhu H; Guo JL Oncotarget; 2016 Mar; 7(12):14188-98. PubMed ID: 26893358 [TBL] [Abstract][Full Text] [Related]
15. Radiosensitization of esophageal carcinoma cells by knockdown of HMGB1 expression. Zhang X; Yang X; Zhu S; Li Q; Zou N Oncol Rep; 2019 Mar; 41(3):1960-1970. PubMed ID: 30569171 [TBL] [Abstract][Full Text] [Related]
16. RNF113A promotes the proliferation, migration and invasion, and is associated with a poor prognosis of esophageal squamous cell carcinoma. Wang L; Hou Z; Hasim A; Abuduerheman A; Zhang H; Niyaz M; Awut I; Upur H; Sheyhidin I Int J Oncol; 2018 Mar; 52(3):861-871. PubMed ID: 29393393 [TBL] [Abstract][Full Text] [Related]
17. Knockdown of DDX46 inhibits proliferation and induces apoptosis in esophageal squamous cell carcinoma cells. Li B; Li YM; He WT; Chen H; Zhu HW; Liu T; Zhang JH; Song TN; Zhou YL Oncol Rep; 2016 Jul; 36(1):223-30. PubMed ID: 27176873 [TBL] [Abstract][Full Text] [Related]
18. E26 Transformation-Specific Transcription Factor ETS2 as an Oncogene Promotes the Progression of Hypopharyngeal Cancer. Liu X; Zhang C; Zhang Z; Zhang Z; Ji W; Cao S; Cai X; Lei D; Pan X Cancer Biother Radiopharm; 2017 Nov; 32(9):327-334. PubMed ID: 29111780 [TBL] [Abstract][Full Text] [Related]
19. miR-675-5p enhances tumorigenesis and metastasis of esophageal squamous cell carcinoma by targeting REPS2. Zhou YW; Zhang H; Duan CJ; Gao Y; Cheng YD; He D; Li R; Zhang CF Oncotarget; 2016 May; 7(21):30730-47. PubMed ID: 27120794 [TBL] [Abstract][Full Text] [Related]
20. Long noncoding RNA H19 is up-regulated in esophageal squamous cell carcinoma and promotes cell proliferation and metastasis. Tan D; Wu Y; Hu L; He P; Xiong G; Bai Y; Yang K Dis Esophagus; 2017 Jan; 30(1):1-9. PubMed ID: 27247022 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]